MyAverix Finance
MC · Healthcare
Grifols S.A. (GRF)
Drug Manufacturers - General
Grifols S.A. (GRF) is listed on MC in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-24, reported market cap is $6.44B, P/E ratio is 18.00, net margin is 5.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GRF
Grifols S.A. (GRF) — FAQ
What is Grifols S.A.'s market cap?
Grifols S.A. (GRF) has a reported market cap of $6.44B (data as of 2026-05-24).
What is GRF's P/E ratio?
The price-to-earnings (P/E) ratio for Grifols S.A. (GRF) is 18.00 (data as of 2026-05-24).
Does Grifols S.A. pay a dividend?
Dividend yield is not available in the current snapshot for Grifols S.A. (GRF). Check the MyAverix Finance app for the latest dividend data.
What sector is Grifols S.A. in?
Grifols S.A. (GRF) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is GRF listed on?
GRF is listed on MC.
What is Grifols S.A.'s net margin?
Grifols S.A. (GRF) reports a net margin of 5.6% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.